Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome

被引:164
|
作者
Konishi, Tsuyoshi [1 ,2 ]
Shimada, Yoshifumi [1 ,3 ]
Hsu, Meier [4 ]
Tufts, Lauren [1 ]
Jimenez-Rodriguez, Rosa [1 ]
Cercek, Andrea [5 ]
Yaeger, Rona [5 ]
Saltz, Leonard [5 ]
Smith, J. Joshua [1 ]
Nash, Garrett M. [1 ]
Guillem, Jose G. [1 ]
Paty, Philip B. [1 ]
Garcia-Aguilar, Julio [1 ]
Gonen, Mithat [4 ]
Weiser, Martin R. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA
[2] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan
[3] Niigata Univ, Grad Sch Med & Dent Sci, Div Digest & Gen Surg, Niigata, Japan
[4] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
COLORECTAL-CANCER; TUMOR-MARKERS; PROGNOSTIC-SIGNIFICANCE; CURATIVE RESECTION; FOLLOW-UP; CEA; LEVEL; STAGE; RECURRENCE; METASTASES;
D O I
10.1001/jamaoncol.2017.4420
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IMPORTANCE Guidelines recommend measuring preoperative carcinoembryonic antigen (CEA) in patients with colon cancer. Although persistently elevated CEA after surgery has been associated with increased risk formetastatic disease, prognostic significance of elevated preoperative CEA that normalized after resection is unknown. OBJECTIVE To investigate whether patients with elevated preoperative CEA that normalizes after colon cancer resection have a higher risk of recurrence than patients with normal preoperative CEA. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort analysiswas conducted at a comprehensive cancer center. Consecutive patients with colon cancer who underwent curative resection for stage I to III colon adenocarcinoma at the center from January 2007 to December 2014 were identified. EXPOSURES Patients were grouped into 3 cohorts: normal preoperative CEA, elevated preoperative but normalized postoperative CEA, and elevated preoperative and postoperative CEA. MAIN OUTCOMES AND MEASURES Three-year recurrence-free survival (RFS) and hazard function curves over time were analyzed. RESULTS A total of 1027 patients (461 [50.4%] male; median [IQR] age, 64 [53-75] years) were identified. Patients with normal preoperative CEA had 7.4% higher 3-year RFS (n = 715 [89.7%]) than the combined cohorts with elevated preoperative CEA (n = 312 [82.3%]) (P =.01) but had RFS similar to that of patients with normalized postoperative CEA (n = 142 [87.9%]) (P =.86). Patients with elevated postoperative CEA had 14.9% lower RFS (n = 57 [74.5%]) than the combined cohorts with normal postoperative CEA (n = 857 [89.4%]) (P =.001). The hazard function of recurrence for elevated postoperative CEA peaked earlier than for the other cohorts. Multivariate analyses confirmed that elevated postoperative CEA (hazard ratio [HR], 2.0; 95% CI, 1.1-3.5), but not normalized postoperative CEA (HR, 0.77; 95% CI, 0.45-1.30), was independently associated with shorter RFS. CONCLUSIONS AND RELEVANCE Elevated preoperative CEA that normalizes after resection is not an indicator of poor prognosis. Routine measurement of postoperative, rather than preoperative, CEA is warranted. Patients with elevated postoperative CEA are at increased risk for recurrence, especially within the first 12 months after surgery.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 50 条
  • [31] CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH BREAST OR COLON CANCER
    LEE, YTN
    WESTERN JOURNAL OF MEDICINE, 1978, 129 (05): : 374 - 380
  • [32] ROLE OF SERUM CARCINOEMBRYONIC ANTIGEN IN PREOPERATIVE DIAGNOSIS OF CANCER IN PATIENTS WITH THYROID-NODULES
    MADEDDU, G
    LANGER, M
    DETTORI, G
    COSTANZA, C
    CANCER, 1980, 45 (10) : 2607 - 2610
  • [33] The association between preoperative serum carcinoembryonic antigen level and liver metastasis in advanced colorectal carcinoma
    Abbas, Pakdel
    Fakhraddin, Naghibalhossaini
    Pooneh, Mokaram
    Ali, Ghaderi Abbas
    Mahyar, Malekzadeh
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S192 - S192
  • [34] Prognostic Implication of Preoperative Serum Albumin to Carcinoembryonic Antigen Ratio in Colorectal Cancer Patients
    Xu, Mingyue
    Liu, You
    Xue, Tianhui
    Ye, Qianwen
    Xiang, Jia
    Liu, Long
    Yan, Bing
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [35] Prognostic determinants for lung cancer patients with preoperative high serum carcinoembryonic antigen levels
    Tomita, M
    Matsuzaki, Y
    Shimizu, T
    Hara, M
    Ayabe, T
    Onitsuka, T
    THORACIC AND CARDIOVASCULAR SURGEON, 2005, 53 (05): : 300 - 304
  • [36] Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer
    Huichuan Yu
    Yanxin Luo
    Xiaolin Wang
    Liangliang Bai
    Pinzhu Huang
    Lei Wang
    Meijin Huang
    Yanhong Deng
    Jianping Wang
    Scientific Reports, 6
  • [37] Comparative evaluation of carcinoembryonic antigen in tissue and serum with grade and stage of colon cancer.
    Bhatnagar, J
    Tewari, HB
    Bhatnagar, M
    Austin, GE
    LABORATORY INVESTIGATION, 1999, 79 (01) : 71A - 71A
  • [38] Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer
    Yu, Huichuan
    Luo, Yanxin
    Wang, Xiaolin
    Bai, Liangliang
    Huang, Pinzhu
    Wang, Lei
    Huang, Meijin
    Deng, Yanhong
    Wang, Jianping
    SCIENTIFIC REPORTS, 2016, 6
  • [39] Monitoring of serum carcinoembryonic antigen levels after curative resection of colon cancer: Setting of cutoff values in accordance with preoperative values.
    Saito, Gota
    Sadahiro, Sotaro
    Okada, Kazutake
    Tanaka, Akira
    Suzuki, Toshiyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] High postoperative carcinoembryonic antigen as an indicator of high-risk stage II colon cancer
    Morimoto, Yoshihiro
    Takahashi, Hidekazu
    Arita, Asami
    Itakura, Hiroaki
    Fujii, Makoto
    Sekido, Yuki
    Hata, Tsuyoshi
    Fujino, Shiki
    Ogino, Takayuki
    Miyoshi, Norikatsu
    Uemura, Mamoru
    Matsuda, Chu
    Yamamoto, Hirofumi
    Mizushima, Tsunekazu
    Doki, Yuichiro
    Eguchi, Hidetoshi
    ONCOLOGY LETTERS, 2022, 23 (05)